A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...

When Therapy Alone Isn't Enough, Options Like TMS and SPRAVATO® Provide Additional Relief OAK BROOK, Ill., April 8, 2025 ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

Discover how the brain's most abundant neurotransmitter, glutamate, is revolutionizing psychiatry and offering new hope for ...

Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...

Treatment with esketamine combined with an SNRI is linked to fewer adverse outcomes than treatment with an SSRI alone.

First off, the basics: Lexapro is an antidepressant approved to treat major depressive disorder and generalized anxiety disorder, says Judith Kastenberg, MD, a psychiatrist at Corporal Michael J.

Abu Dhabi Health Services Company (SEHA) has recently introduced Esketamine nasal spray for the treatment and management of severe depression in adults who have tried other antidepressant treatment ...

Antidepressant discontinuation syndrome (ADS), or antidepressant withdrawal, includes all the symptoms people might experience when they stop taking their antidepressants, such as nausea ...